precision medicine

The latest group of winning technologies has a little something for everyone—from scientists at the lab bench to those in the clinic and even the classroom.

Explore how on-target precision therapies improve patient outcomes and drug tolerability.

In this webinar, Elizabeth Proctor will discuss the latest organoid models that scientists use to advance human disease research, with a focus on promoting drug discovery and precision medicine.

In this webinar, Pinaki Bose and Fei Chen will discuss how scientists use spatial biology techniques to study the tumor microenvironment.

To accelerate research initiatives, scientists can utilize a platform that brings together over 14 petabytes of multimodal data. 

Technological advances and high throughput techniques offer scientists speed and scalability in precision medicine research and applications.

The Proximity Extension Assay quantifies protein biomarkers accurately without wasting important specimens.

Learn how scientists develop antibody drug conjugates as therapies for age-related diseases.   

With nanoliter-scale reaction volumes, microfluidics-based real-time PCR (RT-PCR) devices speed up genomic analyses and library prep.

A new approach to precision medicine efficiently and accurately associates disease biomarkers with clinical evidence. 

A novel platform paves the way for genomics-based oncology testing, with a knowledgebase of actionable biomarkers and help for scientists developing in-house tests.

Precision medicine helps clinicians tailor individual treatments, addressing genetic mutations, tumor microenvironment variations, and therapeutic resistance.

Cutting edge technology delivers cytokines with high purity, high bioactivity, high batch-to-batch consistency, and high stability.

In this webinar, Dr. Kevin Wang will discuss a precision medicine approach for treating traumatic brain injury which uses phenotype biomarkers to monitor disease course and develop novel therapies.

Learn how researchers establish new technologies such as liquid biopsies and targeted biomarker detection to further enhance precision oncology.

Scientists present the latest research on immune cell responses to cancer, the role of epigenetics in cancer, and molecular imaging of the tumor microenvironment.

Dosh Whye will discuss best practices for organoid modeling and how researchers leverage the latest technologies to achieve their goals.

Clive Svendsen, Meritxell Huch, Ameen Salahudeen, and Maksim Plikus will discuss the latest advances in using patient-derived stem cells to create more accurate disease models.

Researchers advance the potential of precision medicine with cutting edge sequencing technology.